CFU scientists develop phytobiotics from Crimean wild plants

| By | Antibiotics, Drug Development, Plant-Based Drugs, R&D

Phytobiotics, a biologically active substance isolated from plants, can become a real alternative to antibiotics, improve the immunity of patients and fight hospital infections, according to Professor Yuri Krivorutchenko, Head of the Department of Microbiology, Virology and Immunology of the Medical Academy of the Crimean Federal University.

“CFU scientists are studying the effect of triterpene glycosides – taurozides isolated from Crimean ivy, artichokes and other plants. Some taurosides, as it turned out, suppress human immunodeficiency virus. Introduction in medical practice of phytobiotics developed in the CFU will be beneficial for the fight against resistant hospital microorganisms, increase the immunity of patients, including those infected with HIV,” CFU press center quoted Mr. Krivorutchenko.

According to scientist, the successful completion of research would lead to the development of technologies for more effective treatment of HIV-infected patients.

To continue and expand promising research, Krivorutchenko’s laboratory received over 10 million rubles for modernization in the framework of the program for the development of the CFU. Scientific work will be carried out in close cooperation with other departments of CFU.

“Since September, all phytoactive substances isolated from the plants of the Crimean flora will be transferred to this laboratory to analyze their activity against various pathogenic bacteria. First, phytobiotics and their combinations will be tested in the fight against so-called “hospital infections” that are resistant to antibiotics. We expect a great effect from a joint interdisciplinary work that will serve for the benefit of Russian medicine,” the press service quotes the words of Vladimir Nazarov, the Associate Professor of the Botany and Plant Physiology and Biotechnology Department of the CFU Tavrija Academy.